Treating dry age-related macular degeneration: 6 things to know

What an eye specialist says about new medications for dry AMD

12:19 PM

Author | Tessa Roy

eyes close up green blue
Getty Images

Do you have questions about treatment of age-related macular degeneration, otherwise known as dry AMD? Anjali Shah, MD, ophthalmologist at Michigan Medicine, has answers.

Here are six things you and your family should know about treating the condition:

1. There's a new medication available for dry AMD

The medication is called pegcetacoplan, or Syfovre, and it was recently approved by the Food and Drug Administration. It has been shown to slow the progression of a severe form of dry AMD called geographic atrophy. It is not approved for other types of dry AMD.

It's important to note that the drug does not reverse or stop progression, but it may delay further vision loss. Based on clinical trials, we estimate that the drug slows the rate of progression by 1-3 months each year. In other words, if the disease was going to progress to a certain stage of severity in 24 months, it would take 27-30 months while on the drug.

2. There’s a specific way it needs to be given

This dry AMD medication needs to be injected into the eye between every 4 and 8 weeks, which requires a doctor's visit each time.

It's unclear how long patients need to be on the medication and  it's likely that the duration of treatment will be different for every person, but most people will need to continue treatment for several years. There are currently no drops or pills to treat dry AMD.

3. There are potential risks and possible side effects to the medicine

The clinical trials suggest that there's about a 10% risk of developing wet macular degeneration in the first year of treatment with Syfovre. Wet macular degeneration can be treated, but it would require different injections in the eye.

In addition, there are always risks to receiving injections of any type of medication in the eye. The biggest risk is getting an infection in the eye, which can cause permanent vision loss. This happens about 1 in every 3,000 injections.

4.  The medication is mostly recommended for a certain type of patient 

Though anyone with geographic atrophy can get the injection, it may only be an ideal treatment for a select group of patients. If the advanced dry AMD is threatening high-resolution central vision, it may have a benefit that increases over time. In the clinical trials, there was no improvement in vision in 1 to 2 years. You should talk to your doctor to find out if this treatment would be appropriate for you.

5. Experts say they haven't seen vision improvement from the medication

In the clinical trials, there was no improvement in vision in the first two years after starting treatment.  The studies suggest that there may be some visual benefit over time, but there is currently no data to confirm that.

6. A retina specialist should be consulted with 

If you have any questions about dry AMD or its treatment, it's best to contact a retina doctor. They can provide you with personalized information and advice.


More Articles About: Ophthalmologist Eye Care & Vision Preventative health and wellness retinal degeneration retinal repair Hospitals & Centers Pharmacy Kellogg Eye Center
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Headshot of Shahzad Mian, M.D.
News Release
Michigan Medicine names new chair of Department of Ophthalmology and Visual Sciences
Shahzad I. Mian, M.D., has been appointed chair of the Department of Ophthalmology and Visual Sciences and the F. Bruce Fralick Professor of Ophthalmology in the Medical School and the Director of the W.K. Kellogg Eye Center
Person's hand holding an aspirin tablet with a glass of water nearby
Health Lab
An aspirin a day? Some older adults who take it may be following outdated advice
Many people aged 50 to 80 who said they take aspirin multiple times a week may not need to do so and could be causing health risks, according to National Poll on Healthy Aging.
Drawing of parent trying to get child's attention who is listening to music on headphones
Health Lab
Are headphones and earbuds exposing your children to noise health risks?
2 in 3 parents in national poll say their child ages 5-12 use personal audio devices; pediatrician offers 4 tips to reduce noise exposure risks
Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants
Older man with hand on forehead, dressed in camouflage clothing
Health Lab
Ketamine helped many severely depressed veterans, study shows
Intravenous (IV) ketamine helped relieve the depression symptoms of half of the veterans who received it at VA hospitals.
art work with flower circle green teal orange yellow pink on display
Health Lab
Quiet strength of nature heals those dealing with cancer
An art exhibition explores the physical and emotional complexities of the cancer journey by combining anatomy with nature.